These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 4063999)
1. The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop. Kallman RF; Brown JM; Denekamp J; Hill RP; Kummermehr J Cancer Res; 1985 Dec; 45(12 Pt 1):6541-5. PubMed ID: 4063999 [No Abstract] [Full Text] [Related]
2. Rotational stress reduces the effectiveness of antitumor drugs in mice. Giraldi T; Perissin L; Zorzet S; Rapozzi V Ann N Y Acad Sci; 1994 Nov; 741():234-43. PubMed ID: 7825811 [No Abstract] [Full Text] [Related]
3. The reckoning of host defence against cancer. Hewitt HB Br J Radiol; 1971 Nov; 44(527):904-5. PubMed ID: 5123616 [No Abstract] [Full Text] [Related]
4. [Autochtonous animal tumors as test models for cancer chemotherapy]. Schmähl D Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Jun; 40(6):173-5. PubMed ID: 5468737 [No Abstract] [Full Text] [Related]
6. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy. Hoffman RM Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987 [TBL] [Abstract][Full Text] [Related]
7. Cancer drug resistance. Proceedings of a workshop held at the XIV International Congress of Chemotherapy. Kyoto, Japan, June 23-28, 1985. Prog Clin Biol Res; 1986; 223():1-235. PubMed ID: 3809191 [No Abstract] [Full Text] [Related]
8. Report of group B of the American Cancer Society Research Workshop on Cancer and Nutrition: panel on animal studies. Cancer Res; 1993 May; 53(10 Suppl):2452s-2454s. PubMed ID: 8485737 [No Abstract] [Full Text] [Related]
9. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo. Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046 [TBL] [Abstract][Full Text] [Related]
10. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer. Eigl BJ; Eggener SE; Baybik J; Ettinger S; Chi KN; Nelson C; Wang Z; Gleave ME Clin Cancer Res; 2005 Jul; 11(13):4905-11. PubMed ID: 16000589 [TBL] [Abstract][Full Text] [Related]
11. Modeling therapy resistance in genetically engineered mouse cancer models. Rottenberg S; Jonkers J Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147 [TBL] [Abstract][Full Text] [Related]
12. Assessing growth and response to therapy in murine tumor models. Reynolds CP; Sun BC; DeClerck YA; Moats RA Methods Mol Med; 2005; 111():335-50. PubMed ID: 15911989 [TBL] [Abstract][Full Text] [Related]
13. Clinical concepts derived from animal chemotherapy studies. Goldin A; Schabel FM Cancer Treat Rep; 1981; 65 Suppl 3():11-9. PubMed ID: 7049366 [TBL] [Abstract][Full Text] [Related]
14. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin. Xu Y; Choi J; Hylander B; Sen A; Evans SS; Kraybill WG; Repasky EA Int J Hyperthermia; 2007 Sep; 23(6):513-27. PubMed ID: 17952765 [TBL] [Abstract][Full Text] [Related]
15. [The use of induced and spontaneous animal neoplasms in the experimental therapy of tumors]. Anikin IV; Pliss GB; Vlasov NN Vopr Onkol; 1993; 39(4-6):161-8. PubMed ID: 7975390 [No Abstract] [Full Text] [Related]
17. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363 [TBL] [Abstract][Full Text] [Related]
18. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice. Feleszko W; Mlynarczuk I; Balkowiec-Iskra EZ; Czajka A; Switaj T; Stoklosa T; Giermasz A; Jakóbisiak M Clin Cancer Res; 2000 May; 6(5):2044-52. PubMed ID: 10815931 [TBL] [Abstract][Full Text] [Related]
19. [Combined use of radiosensitizing and protective agents in experimental radiotherapy]. Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748 [TBL] [Abstract][Full Text] [Related]
20. In vivo opossum xenograft model for cancer research. Wang Z; Hubbard GB; Pathak S; VandeBerg JL Cancer Res; 2003 Oct; 63(19):6121-4. PubMed ID: 14559788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]